Abstract
A 4-y-old boy with nephropathic cystinosis and gastrointestinal dysmotility of unknown etiology was treated with i.v. cysteamine over a period of 10 mo. Thirty minutes after a dose of 10 mg/kg cysteamine free base, the leukocyte cystine value had fallen from 11.9 to 4.9 nmol of half-cystine/mg of protein. When cysteamine was given every 6 h, the leukocyte cystine concentration, measured 5–7 h after a dose, decreased with increasing cysteamine doses up to 17 mg/kg; at this dose the cystine value was 1.1 nmol of half-cystine/mg of protein, or 9% of the untreated value. Oral administration of approximately 16 mg/kg per dose every 6 h to this patient over the previous 3 y achieved similar leukocyte cystine depletion, to 1.2 nmol of half-cystine/mg of protein. The plasma cysteamine concentration 30 min after a dose of 10 mg/kg was 71 μM; 5-7 h after a dose of up to 20 mg/kg, the concentration was below 5 μM. Dimeth-ylsulfide was elevated in the breath and urine of this boy after, but not before, the initiation of i.v. cysteamine therapy. Ten months after the start of therapy, the patient tolerated 250 mg (14 mg/kg) every 8 h. Adverse effects of this treatment included lethargy and increased nausea and vomiting when a schedule of therapy every 6 h was attempted. This investigation demonstrates that cysteamine given through a central venous catheter is effective in reducing leukocyte cystine levels.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gahl, W., Ingelfinger, J., Mohan, P. et al. Intravenous Cysteamine Therapy for Nephropathic Cystinosis. Pediatr Res 38, 579–584 (1995). https://doi.org/10.1203/00006450-199510000-00018
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1203/00006450-199510000-00018
This article is cited by
-
Cysteamine revisited: repair of arginine to cysteine mutations
Journal of Inherited Metabolic Disease (2017)
-
Dimethylsulphidemia: the significance of dimethyl sulphide in extra-oral, blood borne halitosis
British Dental Journal (2013)
-
Maternal uniparental heterodisomy of chromosome 17 in a patient with nephropathic cystinosis
European Journal of Human Genetics (2009)
-
Intravenous delivery of cysteamine for the treatment of cystinosis: association with hepatotoxicity
Pediatric Nephrology (2008)